Clinical Trial Update: Long-Term Treatment With rhIGF-1 in GHIS [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial updates long-term treatment with rhIGF-1 in Growth Hormone Insensitivity Syndrome; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Insensitivity Syndrome

Drugs mentioned

• rhIGF-1 (insulin-like growth factor-1)

Snippet

Sponsor: Ipsen | Conditions: Growth Hormone Insensitivity Syndrome | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-07-06